Humacyte Inc (HUMA) Stock Price, Quote & News

Company Profile

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It...

Industry: Biotechnology

Sector: Healthcare

Phone: 919-313-9633

Website: humacyte.com

Address:

2525 East North Carolina Highway 54, Durham, United States

GJ_Rockabilt Jun. 23 at 5:14 PM

$CRMD I can't justify paying over $16 per Share on CRMD, right now, while I Own Humacyte Warrants at $0.49. $HUMA Shares are less than $2.25! The Company has Phase III Hemodialysis Studies, ONGOING.

2 · Reply

GJ_Rockabilt Jun. 23 at 5:02 PM

$HUMA is RELEVANT. See what former Trump Foreign Policy Advisor, George Papadopoulos, Reveals about Sleeper Cells: https://x.com/infowars/status/1936978199382003775?t=C7XQvGQV-ypYebTr2_uVew&s=19

0 · Reply

JuniperLuna Jun. 23 at 4:44 PM

$HUMA

1 · Reply

JuniperLuna Jun. 23 at 4:42 PM

$HUMA At least we aren't HIMS today... But damn, all my individual stocks are down like 10%.

0 · Reply

crowbaby333 Jun. 23 at 4:36 PM

$HUMA institutions aren’t selling. Retail is moving away from riskier assets across the board. Good news for huma all around. - War - ECAT - Q2 earnings - NTAP possibly. - SBLA dialysis Just need to survive the macro

0 · Reply

andrewh2024 Jun. 23 at 4:31 PM

$HUMA this is just brutal but sadly not shocking. There's no news so this is purely shorts shaking everyone out...again.

0 · Reply

Phillvsthemarket Jun. 23 at 4:13 PM

$HUMA we have problem

0 · Reply

MrStockPick Jun. 23 at 4:09 PM

$HUMA bought more, this is all shorting, more than 350,000 shares disappeared today currently no more shares to short

0 · Reply

VALMS Jun. 23 at 4:05 PM

$HUMA bought more.

0 · Reply

GJ_Rockabilt Jun. 23 at 1:33 PM

$HUMA , HUMAW : Delicious SHORT SQUEEZE, SHORT INTEREST STATS FOR HUMA: Short Interest: 31,799,416 shares - source: NASDAQ Short Interest Ratio: 21.56 Days to Cover Short Interest % Float: 26.08 % - source: NASDAQ (short interest), Capital IQ (float) Off-Exchange Short Volume343,564 shares - source: FINRA (includes Dark Pool volume) Off-Exchange Short Volume Ratio: 59.71 % - source: FINRA (includes Dark Pool volume)

2 · Reply

Humacyte: Revenue Ramp From Symvess Incoming

Jun 9, 2025, 8:00 AM EDT - 14 days ago

Results from Humacyte's V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting

Jun 2, 2025, 8:00 AM EDT - 21 days ago

Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3

May 19, 2025, 4:05 PM EDT - 4 weeks ago

Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq

May 13, 2025, 2:29 PM EDT - 5 weeks ago

Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript

May 13, 2025, 7:30 AM EDT - 5 weeks ago

Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update

May 9, 2025, 8:00 AM EDT - 6 weeks ago

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

Mar 28, 2025, 1:48 PM EDT - 3 months ago

Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript

Mar 28, 2025, 7:30 AM EDT - 3 months ago

Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Mar 26, 2025, 8:00 AM EDT - 3 months ago

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

Mar 25, 2025, 8:35 PM EDT - 3 months ago

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

Mar 25, 2025, 4:01 PM EDT - 3 months ago

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Mar 10, 2025, 8:00 AM EDT - 3 months ago

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

Mar 6, 2025, 8:00 AM EST - 3 months ago

Trestle Bio Announces Research Collaboration with Humacyte

Mar 3, 2025, 8:00 AM EST - 4 months ago

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

Feb 27, 2025, 4:05 PM EST - 4 months ago

Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

Feb 27, 2025, 8:00 AM EST - 4 months ago

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

Feb 26, 2025, 8:00 AM EST - 4 months ago

Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

Feb 20, 2025, 1:35 PM EST - 4 months ago

Humacyte, Inc. - Investors of Humacyte Stock Encouraged to Contact Kehoe Law Firm, P.C. - HUMA

Jan 21, 2025, 8:00 AM EST - 5 months ago

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting

Jan 17, 2025, 10:30 AM EST - 5 months ago

HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Jan 9, 2025, 5:45 AM EST - 5 months ago

Investors in Humacyte, Inc. Should Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA

Jan 2, 2025, 8:15 AM EST - 6 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

GJ_Rockabilt Jun. 23 at 5:14 PM

$CRMD I can't justify paying over $16 per Share on CRMD, right now, while I Own Humacyte Warrants at $0.49. $HUMA Shares are less than $2.25! The Company has Phase III Hemodialysis Studies, ONGOING.

2 · Reply

GJ_Rockabilt Jun. 23 at 5:02 PM

$HUMA is RELEVANT. See what former Trump Foreign Policy Advisor, George Papadopoulos, Reveals about Sleeper Cells: https://x.com/infowars/status/1936978199382003775?t=C7XQvGQV-ypYebTr2_uVew&s=19

0 · Reply

JuniperLuna Jun. 23 at 4:44 PM

$HUMA

1 · Reply

JuniperLuna Jun. 23 at 4:42 PM

$HUMA At least we aren't HIMS today... But damn, all my individual stocks are down like 10%.

0 · Reply

crowbaby333 Jun. 23 at 4:36 PM

0 · Reply

andrewh2024 Jun. 23 at 4:31 PM

$HUMA this is just brutal but sadly not shocking. There's no news so this is purely shorts shaking everyone out...again.

0 · Reply

Phillvsthemarket Jun. 23 at 4:13 PM

$HUMA we have problem

0 · Reply

MrStockPick Jun. 23 at 4:09 PM

$HUMA bought more, this is all shorting, more than 350,000 shares disappeared today currently no more shares to short

0 · Reply

VALMS Jun. 23 at 4:05 PM

$HUMA bought more.

0 · Reply

GJ_Rockabilt Jun. 23 at 1:33 PM

2 · Reply

GJ_Rockabilt Jun. 23 at 1:28 PM

$HUMA , HUMAW : Vast majority of Bears Shorting HUMAW Warrants have left, evidently, for greener pastures. Thanks to all who helped run them off by ensuring they couldn't make much money by riding the Warrants up, then Selling to place Shorts on $HUMA SHARES. Short Squeeze, Short Interest Stats on HUMAW Warrants: Short Interest: 7,421 shares - source: NASDAQ Short Interest Ratio: 0.85 Days to Cover Off-Exchange Short Volume268 shares - source: FINRA (includes Dark Pool volume) Off-Exchange Short Volume Ratio: 3.29 % - source: FINRA (includes Dark Pool volume)

0 · Reply

Pitchie Jun. 23 at 9:32 AM

$HUMA

0 · Reply

moneyisfunduhr Jun. 22 at 10:43 PM

$HUMA https://x.com/SecKennedy/status/1936199106936160516?t=U0lf_w63Rq117h3BVMqZ4A&s=19 Finally, Sec Kennedy moving to cut red tape on US Biotech! #MABA now we just need an expedited NTAP and ECAT listings and we gucci

0 · Reply

David_M_ Jun. 22 at 6:51 PM

$HUMA https://finance.yahoo.com/news/owning-40-shares-institutional-owners-133232776.html

0 · Reply

JuniperLuna Jun. 21 at 11:56 PM

$HUMA breaking: US has bombed irans nuclear site

3 · Reply

LuckEtradER Jun. 21 at 1:38 AM

$HUMA

0 · Reply

DARK_MAGA_SCROOGIE Jun. 20 at 11:27 PM

$APLD why is marketpro touting his horn like he's some kind of stock guru? he is one of the worst investors i've seen on here. He recommended me stocks like $HUMA $SDOT $CHRS lmao and look at all those charts. quiet down marketpro. You called the stock price horribly in the past year here. you're bound to get one call right. Here's marketpro waiting for his stock to turn green LMAO.

1 · Reply

moneyisfunduhr Jun. 20 at 5:58 PM

$HUMA really hope Laura gets an audience with Hegseth and the DoD boys

1 · Reply

andrewh2024 Jun. 20 at 4:54 PM

$HUMA no volume. Just shorts eating. We will have our day. Carry on. NFA. GLTA.

0 · Reply

HectorNumba9 Jun. 20 at 3:07 PM

$ICU i hate it too. Look at $GALT . Look at $HUMA . $AKBA science always wins. Only certain like $TNXP is a scam😂

1 · Reply

Babyimbullish Jun. 20 at 2:53 PM

$HUMA this is a silent killer. before you know it itll run heavy. people dying left and right and people need this

1 · Reply

GJ_Rockabilt Jun. 20 at 2:34 PM

$HUMA Short Squeeze, Short Interest Stats; 👇👇👇👇👇👇

1 · Reply

Market Cap	358.33M
Revenue (ttm)	0.00
Net Income (ttm)	-148.70M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	2,490,379
Avg Vol	4,190,776
Day's Range	N/A - N/A
Shares Out	155.12M
Stochastic %K	9%
Beta	2.00
Analysts	Strong Sell
Price Target	$9.43